-
1مورد إلكتروني
مصطلحات الفهرس: SLEDAI, social status, systemic lupus erythematosus/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], beta2 glycoprotein 1 antibody/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], double stranded DNA antibody/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], La antibody/ec [Endogenous Compound], leflunomide/dt [Drug Therapy], lupus anticoagulant/ec [Endogenous Compound], mercaptopurine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rheumatoid factor/ec [Endogenous Compound], ribonucleoprotein antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], high disease activity status, adult, article, clinical feature, clinical outcome, comparative study, corticosteroid therapy, demography, disease activity, disease activity score, disease severity, female, human, major clinical study, male, middle aged, observational study, physician, priority journal, scoring system, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29232
Click here for full text options
LibKey Link -
2مورد إلكتروني
مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link -
3مورد إلكتروني
مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29085
Arthritis Care and Research
Click here for full text options
LibKey Link -
4مورد إلكتروني
مصطلحات الفهرس: belimumab/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], prednisolone/dt [Drug Therapy], remission, clinical effectiveness, disease association, disease severity, drug efficacy, drug exposure, human, note, priority journal, rheumatoid arthritis, risk assessment, systemic lupus erythematosus/dt [Drug Therapy], Note
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35466
Click here for full text options
LibKey Link -
5مورد إلكتروني
مصطلحات الفهرس: SLEDAI, social status, systemic lupus erythematosus/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], beta2 glycoprotein 1 antibody/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], double stranded DNA antibody/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], La antibody/ec [Endogenous Compound], leflunomide/dt [Drug Therapy], lupus anticoagulant/ec [Endogenous Compound], mercaptopurine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rheumatoid factor/ec [Endogenous Compound], ribonucleoprotein antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], high disease activity status, adult, article, clinical feature, clinical outcome, comparative study, corticosteroid therapy, demography, disease activity, disease activity score, disease severity, female, human, major clinical study, male, middle aged, observational study, physician, priority journal, scoring system, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29232
Lupus Science and Medicine
LibKey Link -
6مورد إلكتروني
مصطلحات الفهرس: immunosuppressive agent/pe [Pharmacoeconomics], prednisolone/dt [Drug Therapy], prednisolone/pe [Pharmacoeconomics], American College of Rheumatology Damage Index, flare index, lupus low disease activity state, Physician Global Assessment, Systemic Lupus International Collaborating Clinic, human, adult, article, cohort analysis, controlled study, demography, drug cost, drug use, female, health care cost, health care utilization, hospital information system, longitudinal study, lupus erythematosus nephritis, major clinical study, male, medical history, scoring system, SLEDAI, systemic lupus erythematosus/dm [Disease Management], systemic lupus erythematosus/dt [Drug Therapy], tertiary care center, immunosuppressive agent/dt [Drug Therapy], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29084
Arthritis Care and Research
LibKey Link -
7مورد إلكتروني
مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link -
8مورد إلكتروني
مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29085
Arthritis Care and Research
LibKey Link -
9مورد إلكتروني
مصطلحات الفهرس: belimumab/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], prednisolone/dt [Drug Therapy], remission, clinical effectiveness, disease association, disease severity, drug efficacy, drug exposure, human, note, priority journal, rheumatoid arthritis, risk assessment, systemic lupus erythematosus/dt [Drug Therapy], Note
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35466
The Lancet Rheumatology
LibKey Link -
10مورد إلكتروني
مصطلحات الفهرس: disease severity, dysarthria, female, granule cell, histopathology, human, human tissue, immune deficiency, immunohistochemistry, immunosuppressive treatment, JC virus, letter, lymphocyte count, lymphocytopenia/di [Diagnosis], middle aged, mortality, adult, arthralgia/dt [Drug Therapy], ataxia, bedridden patient, blood cell count, brain biopsy, case report, clinical article, computer assisted tomography, coordination disorder/di [Diagnosis], demyelination/di [Diagnosis], diplopia, disease exacerbation, neuroimaging, neuropathy/di [Diagnosis], nuclear magnetic resonance imaging, nystagmus/di [Diagnosis], oscillopsia, physical examination, polymerase chain reaction, priority journal, Simian virus 40, systemic lupus erythematosus/dt [Drug Therapy], tremor, virus infection/di [Diagnosis], virus reactivation, folic acid/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], prednisolone/dt [Drug Therapy], holmes tremor, Letter
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35616
Internal Medicine Journal
Click here for full text options
LibKey Link